Efficacy and safety of brentuximab vedotin versus standard therapy for cutaneous T-cell lymphoma: A systematic review and meta-analysis
Department
Internal Medicine
Document Type
Conference Proceeding
Publication Title
Blood
Conference Name
American Society of Hematology (ASH) Annual Meeting
Conference Date
2025-12-06 - 2025-12-09
First Page
7173
DOI
10.1182/blood-2025-7173
Volume
146
Issue
Supplement 1
Publication Date
11-3-2025
Recommended Citation
Ahmed, U., Azim, D., Ahmed, J., Kabir, A., Hafeez, A., Burhan, M., Saleem, A., & Saleem, M. A. (2025). Efficacy and safety of brentuximab vedotin versus standard therapy for cutaneous T-cell lymphoma: A systematic review and meta-analysis. Blood, 146 (Supplement 1), 7173. https://doi.org/10.1182/blood-2025-7173
COinS